Ayumi Maeda

Ayumi Maeda

Auto-generated profile, based on publicly available information

Ayumi Maeda

Affiliation Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States of America

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2024 in International Journal of Obstetric Anesthesia
Verified
Journal Article
Closed access
RARachel A. Achu-Lopes
Rachel A. Achu-Lopes
LTL.C. Tsen
L.C. Tsen
GOG. Ovsak
G. Ovsak
NRN.A. Raheel
N.A. Raheel
MFM.K. Farber
M.K. Farber
AMA. Maeda
A. Maeda

5 October 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAyumi Maeda
Ayumi Maeda
RSRimu Suzuki
Rimu Suzuki
RMRie Maurer
Rie Maurer
SKSumie Kurokawa
Sumie Kurokawa
MKMiki Kaneko
Miki Kaneko
YNYasuko Nagasaka
Yasuko Nagasaka
Enhanced recovery is the gold standard in modern perioperative management, including that for cesarean deliveries. However, qualitative and quantitative data on the physical and psychological recovery of women after vaginal childbirth are limited. Whether neuraxial labor analgesia influences postpartum recovery is unknown. Primiparous women anticipating a vaginal childbirth between January 2020 and May 2021 were enrolled. Women with major comorbidities or postpartum complications and those who underwent a cesarean delivery were excluded. Daily step count was measured using a wrist-worn activity tracker (FitbitTM Inspire HR) for 120 hours after vaginal childbirth. Subjective fatigue levels and health-related quality of life were assessed using the Multidimensional Fatigue Inventory (MFI) and EuroQol 5 Dimension 5 Level (EQ-5D-5L), respectively, at the 3rd trimester antenatal visit, on postpartum day 1 and 3, and at the one-month postpartum visit. Rest and dynamic pain scores and the location of pain were documented by participants during postpartum hospitalization. Among 300 women who were enrolled antenatally, 95 and 116 had a vaginal delivery without (NCB group) and with (EPL group) epidural analgesia, respectively. The median number of steps per 24 hours increased daily in both groups, and no significant difference was detected between the groups. Postpartum pain was mild overall, with median rest and dynamic pain scores being less than 4 and similar between the groups. MFI and EQ-5D-5L scores were the worst on postpartum day 1 in both groups and gradually improved to antepartum level by the one-month postpartum visit. Higher MFI score on postpartum day 1, but not the use of epidural analgesia, was associated with lower odds of achieving adequate postpartum ambulation (defined as >3500 steps between 48 and 72 hours postpartum). The use of epidural analgesia was not associated with worse recovery outcomes during postpartum hospitalization. UMIN-CTR, #UMIN000039343, registered on January 31, 2020.

18 April 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAyumi Maeda
Ayumi Maeda
GSGen Shimada
Gen Shimada
NFNobuko Fujita
Nobuko Fujita
RSRimu Suzuki
Rimu Suzuki
MYMichiko Yamanaka
Michiko Yamanaka
YNYasuko Nagasaka
Yasuko Nagasaka
Background: Few data are available on the intensity of pain that women experience during the first five days after vaginal childbirth. Moreover, it is unknown if the use of neuraxial labor analgesia has any impact on the level of postpartum pain. Methods: We performed a retrospective cohort study based on chart review of all women who delivered vaginally at an urban teaching hospital between April 2017 and April 2019. The primary outcome was the area under the curve of pain score on numeric rating scale (NRS) documented in electronic medical records for five days postpartum (NRS-AUC5days). Secondary outcomes included peak NRS score, doses of oral and intravenous analgesics consumed during the first five days postpartum, and relevant obstetric outcomes. Logistic regression was used to examine the associations between the use of neuraxial labor analgesia and pain-related outcomes adjusting for potential confounders. Results: During the study period, 778 women (38.6%) underwent vaginal delivery with neuraxial analgesia and 1240 women (61.4%) delivered without neuraxial analgesia. Median (Interquartile range) of NRS-AUC5days was 0.17 (0.12–0.24) among women who received neuraxial analgesia and 0.13 (0.08–0.19) among women who did not (p<0.001). Women who received neuraxial analgesia were more likely to require the first- and second-line analgesics postpartum than women who did not: diclofenac (87.9% vs. 73.0%, p< 0.001, respectively); acetaminophen (40.7% vs. 21.0%, p< 0.001, respectively). The use of neuraxial labor analgesia was independently associated with increased odds of having NRS-AUC5days in the highest 20 percentile (adjusted odds ratio [aOR] 2.03; 95% confidence interval [CI] 1.55–2.65), having peak NRS ≥ 4 (aOR 1.54; 95% CI 1.25–1.91) and developing hemorrhoids during the postpartum hospitalization (aOR 2.13; 95% CI 1.41–3.21) after adjusting for relevant confounders. Conclusion: Although women who used neuraxial labor analgesia had slightly higher pain scores and increased analgesic requirement during postpartum hospitalization, pain after vaginal childbirth was overall mild. The small elevation in the pain burden in neuraxial group does not seem to be clinically relevant and should not influence women’s choice to receive labor analgesia.

9 July 2026 in International Journal of Obstetric Anesthesia
Verified
Journal Article
Closed access
DBDaniel F. Berenson
Daniel F. Berenson
BEBraden E. Eberhard
Braden E. Eberhard
RKRicardo Kleinlein
Ricardo Kleinlein
NWNolan K. Wheeler
Nolan K. Wheeler
AMAyumi Maeda
Ayumi Maeda
VKVesela P. Kovacheva
Vesela P. Kovacheva